Document:

<PAGE>

Exhibit 10.17

                            VANTAGEMED CORPORATION
                             EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT made as of this 30th day of April, 1998 by and
between VantageMed Corporation ("Company"), and Gregory F. Vap ("Employee").

     WHEREAS, the Company and Employee desire to enter into an employment
contract that will govern the terms and conditions of Employee's employment
with the Company.

     NOW, THEREFORE, the parties hereto agree as follows:

     1.  TITLE. Employee shall serve as Senior Vice President--Midwest
Operations for the Company.

     2.  DUTIES AND RESPONSIBILITIES. Employee shall have senior management
responsibilities in, among other areas, the areas of sales and marketing,
operations, support, and Regional operational responsibilities for profit and
loss for the Company's Midwest operations. In addition, Employee shall have
the responsibility to hire and fire Company employees, in addition to general
operational responsibilities as would ordinarily be entrusted to a
subsidiary's senior executive officer. Employee hereby agrees to perform in
good faith and to the best of his ability all services which may be required
of Employee in such position and to be available to render such services at
all reasonable times and places in accordance with such reasonable directions
and requests as the Company may from time to time reasonably specify.
Employee shall, during the Employment Period (as defined below), devote as
required his business time, ability, energy and skill to the performance of
his duties and responsibilities hereunder.

     3.  PERIOD OF EMPLOYMENT. The period of Employee's employment with the
Company pursuant to the provisions of this Agreement shall commence as of the
date hereof and shall, unless sooner terminated in accordance with Paragraph
10 herein, continue for three years from the date hereof, or until twelve
(12) months after the Company has been the subject of a successful initial
public offering ("IPO"), whichever shall occur first. Thereafter, employment
pursuant to this Agreement may be renewed as mutually agreed by the parties
hereto in writing.

     4.  COMPENSATION. During the Employment Period, Employee shall be paid
at a rate of $125,000 per year. Employee shall be paid in twice-monthly
intervals over the Employment Period, in accordance with the Company's
standard payroll practices. The Company shall deduct and withhold from
Employee's compensation payable hereunder any and all applicable federal
state and local income and employment withholding taxes and any other
amounts required to be deducted or withheld by the Company under applicable
statutes, regulations, ordinances or orders governing or requiring the
withholding or deduction of amounts otherwise payable as compensation or
wages to employees. Employee shall also be eligible for sales override
bonuses as determined by Employee's direct supervisor.

<PAGE>

     5.  BUSINESS EXPENSE REIMBURSEMENT. Employee shall be entitled, in
accordance with the reimbursement policies in effect from time to time, to
receive reimbursement from the Company for all travel and other reasonable
business expenses incurred by Employee in the performance of his duties
hereunder, provided Employee furnishes the Company with vouchers, receipts
and other details of such expenses in accordance with the Company policies.

     6.  BENEFITS. Company shall provide Employee all medical, dental, life
and other benefit plan coverage as provided in Section V.16 of the "Agreement
and Plan of Merger" executed by Company and Employee, among others. Employee
shall accrue 1.67 days of paid vacation per month of employment with Company.
Such accrued days of paid vacation may be carried over from month to month
and year to year until used by Employee. Employee shall receive seven paid
holidays per year, the timing of such holidays to be determined by the
Company. Employee shall also accrue four hours of sick leave per month for a
maximum of six days per year. For the purpose of determining any benefit, or
the amount of any benefit, to which Employee may be entitled, his period of
service with Healthcare Information Systems, Inc. shall be deemed to have
been service in the employ of Company.

     7.  RESTRICTIVE COVENANT. During the Employment Period:

         A.  Employee shall devote, as required, his business time, ability,
energy and skill to the performance of Employee's duties and responsibilities
described herein, except during periods of illness or vacation.

         B.  Employee shall not directly or indirectly provide services to or
through any person, firm or other entity except the Company, unless otherwise
authorized by the Company in writing.

         C.  Employee shall not render any services of any kind or character
for Employee's own account or for any other person, firm or entity without
first obtaining the Company's written consent.

         D.  Notwithstanding the foregoing, Employee shall have the right to
perform such incidental services as are necessary in connection with (i) his
private passive investments, but only if Employee is not obligated or
required to (and shall not in fact) devote any managerial efforts which
interfere with the services required to be performed by him hereunder, (ii)
his charitable or community activities, or (iii) participation in trade or
professional organizations, but only if such incidental services do not
significantly interfere with the performance of Employee's services
hereunder, subject to Section 8 below:

     8.  NON-COMPETITION.

                                       2

<PAGE>

         A.  During the Employment Period, Employee shall not directly or
indirectly:

             (i)  own, manage, operate, join, control or participate in the
ownership, management, operation or control of, or be employed by or
connected in any manner with, any enterprise which is engaged in any business
competitive with that which the Company is at the time conducting or
proposing to conduct; PROVIDED, however, that such restriction shall not
apply to any passive investment representing an interest of less than two
percent (2%) of an outstanding class of publicly traded securities of any
corporation or other enterprise which is not, at the time of such investment,
engaged in a business geographically competitive with the Company's business;
or

            (ii) encourage or solicit any Company employee to leave the
Company's employ for any reason or interfere in any material manner with
employment relationships at the time existing between the Company and its
current employees, except as may be required in any bona fide termination
decision regarding any Company employee.

         B.  Employee acknowledges that the services that he shall provide to
the Company under this Agreement are unique and that irreparable harm shall
be suffered by the Company in the event of the breach of Employee of any of
his obligations under this Paragraph 8 or under Paragraph 7, and that the
Company shall be entitled, in addition to its other right and remedies,
whether legal or equitable, to enforce such obligations by an injunction or
decree of specific performance. Any claims asserted by Employee against the
Company shall not constitute a defense in any injunction action brought by
the Company to obtain specific performance of such obligations.

     9.  PROPRIETARY INFORMATION. Concurrent with execution of this
Agreement, Employment shall execute the Company's standard form of employee
proprietary information and inventions agreement attached hereto as EXHIBIT A.

     10. TERMINATION OF EMPLOYMENT.

         A.  Subject to applicable law and during the Employment Period,
Employee's service with the Company may only be terminated by the Company for
good and sufficient cause. For purposes of this Agreement, "cause" shall mean
(i) Employee's repeated failure or refusal to perform his duties and
responsibilities set forth herein, and upon thirty (30) days written notice
his failure to cure such failure or refusal, (ii) conviction of any felony
involving moral turpitude, fraud or misrepresentation, (iii) any willful or
intentional act with the intent to and having the effect of substantially and
materially injuring the reputation, business or business relationships of the
Company, or (iv) any material breach of any of the provisions of this
Agreement by Employee which is not cured within thirty (30) days after
written notice thereof to Employee.

                                       3

<PAGE>

         B.  In the event Employee's employment with the Company is
terminated without good and sufficient cause, Employee's contract shall be
paid in full, including salary and all benefits, for the entire period of
employment set forth in paragraph 3 above. In the event that Employee's
employment with the Company terminates as a result of Employee's decision to
seek other employment, or as a result of death or disability or for any other
reason, Employee shall receive severance pay for a period of three months or
the remaining term of this Agreement, whichever is less.

     11. SUCCESSORS AND ASSIGNS.  The provisions of this Agreement shall
inure to the benefit of, and shall be binding upon, the Company, its
successors and assigns, and Employee, the personal representative of his
estate and his heirs and legatees.

     12. GOVERNING DOCUMENT.  This Agreement constitutes the entire agreement
and understanding of the Company and Employee with respect to the terms set
forth herein and supersedes all prior and contemporaneous written or verbal
agreements and understandings between Employee and the Company relating to
such subject matter, other than as provided herein. This Agreement may only
be amended by written instrument signed by Employee and the Company's
President and Chief Executive Officer, Joel Harris. Any and all prior
agreements, understandings or representations relating to Employee's
employment with the Company are hereby terminated and cancelled in their
entirety and are of no further force or effect.

     13. APPLICABLE LAW.  This Agreement shall, in all respects, be governed
by the laws of the State of California applicable to agreements executed and
to be wholly performed within the State of California.

     14. MEDIATION.  Employee and the Company agree that before any dispute
between the two arising under or related to this Agreement is brought to
trial before a judge or jury each shall make a good-faith attempt to resolve
such dispute through non-binding mediation. However, failure to make such
good-faith attempt will not be a bar to initiating, pursuing or concluding
formal litigation in any court of competent jurisdiction.

     15. COUNTERPARTS.  This Agreement may be executed in more than one
counterpart, each of which shall be deemed an original, but all of which
together shall constitute but one and the same instrument.

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the
day and year written above.

                                       VANTAGEMED CORPORATION

Date: April 30 , 1998.                 By: /s/ Joel Harris
     ----------                           ------------------------------
                                       Title: PRESIDENT
                                             ---------------------------

                                       4

<PAGE>

Date: April 30 , 1998.                 /s/ Gregory F. Vap
     ----------                        ---------------------------------
                                       Gregory F. Vap<PAGE>

                                                                EXHIBIT 4.3

--------------------------------------------------------------------------------

THE SECURITIES REPRESENTED BY THIS CERTIFICATE OR INSTRUMENT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE
SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, PLEDGED OR TRANSFERRED IN THE
ABSENCE OF REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT OR LAWS. SUCH
SECURITIES ARE ALSO SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER, AS SET FORTH
IN THAT CERTAIN WARRANT AGREEMENT DATED JULY 31, 1996, AS SUPPLEMENTED BY THAT
CERTAIN SUPPLEMENT TO WARRANT AGREEMENT DATED AS OF AUGUST 31, 1999.

--------------------------------------------------------------------------------

                          VARI-LITE INTERNATIONAL, INC.
                          Common Stock Purchase Warrant
                    Representing Right To Purchase Shares of
                                  Common Stock
                                       of
                          Vari-Lite International, Inc.

                                     No. A-5

         FOR VALUE RECEIVED, VARI-LITE INTERNATIONAL, INC., a Delaware
  corporation (the "Company"), hereby certifies that CHASE BANK OF TEXAS, N.A.
  (the "Holder'), is entitled, subject to the provisions of this Warrant, to
  purchase from the Company, at any time or from time to time during the
  Exercise Period (as hereinafter defined), a total of 53,824 shares (as such
  number of shares may be adjusted pursuant to the terms hereof and pursuant to
  Section 2.01 of the Warrant Agreement (as hereinafter defined), the "Warrant
  Shares") of Common Stock (as defined in the Warrant Agreement), at a price per
  share equal to the Exercise Price (as hereinafter defined). This Warrant is
  issued to the Holder (together with such other warrants as may be issued in
  exchange, transfer or replacement of this Warrant, the "Warrants") pursuant to
  the Warrant Agreement and entities the Holder to purchase the Warrant Shares
  (as hereinafter defined) and to exercise the other rights, powers and
  privileges hereinafter provided, all on the terms and conditions and pursuant
  to the provisions set forth herein and in the Warrant Agreement.

         Section 1. DEFINITIONS. Terms defined in the Warrant Agreement (as
hereinafter defined) and not otherwise defined herein have, as used herein, the
respective meanings provided

<PAGE>

for therein. The following additional terms, as used herein, have the
following respective meanings:

         "Common Stock" shall mean and include collectively the Company's
authorized Common Stock, $0.10 par value, as constituted on the date hereof.

         "Date of Issuance" shall have the meaning ascribed to such term in
Section 8 hereof.

         "Distributions" shall have the meaning ascribed to such term in
Section 4.1(c) hereof.

         "Exercise Period" shall mean the period of time between the Date of
Issuance and 5:00 P.M. (New York City time) on December 31, 2004.

         "Exercise Price" shall mean an amount, per share, equal to $3.75;
PROVIDED, HOWEVER, that such amount is subject to adjustment as set forth in
Section 4 hereof.

         "Fair Market Value" shall mean, as of any date of determination, with
respect to any class of equity security of the Company (including any equity
security issuable upon exercise of any warrant (including the Warrants) or
option to acquire such equity security), (x) if there is a Qualified Public
Market for such class of equity security the value per share determine pursuant
to clause (i) or (ii) below of this definition or (y) if there is no such
Qualified Public Market, the value determined pursuant to clause (iii) below of
this definition:

                  (i) if such equity security is listed on a national securities
                  exchange or admitted to unlisted trading privileges on such an
                  exchange, the average last reported sale price (as reported in
                  THE WALL STREET JOURNAL) of a share of such equity security
                  over the 21 trading day period immediately prior to the date
                  of determination or if no such sale is made on any such day,
                  the mean of the closing bid and asked prices for such day on
                  such exchange; or

                  (ii) if such equity security is not so listed or admitted to
                  unlisted trading privileges, the average mean of the last bid
                  and asked prices reported for a share of such equity security
                  over the 21 trading day period immediately prior to the date
                  of determination (A) by the National Association of Securities
                  Dealers Automatic Quotation System or (B) if reports are
                  unavailable under clause (A) above by the National Quotation
                  Bureau Incorporated; or

                  (iii) if such equity security is not so listed or admitted to
                  unlisted trading privileges and bid and asked prices are not
                  so reported, then the Company shall give prompt, written
                  notice to each Holder of the need to determine the Fair Market
                  Value of such equity security, as well as a statement of the
                  fair market value of such equity security determined by the
                  Board of Directors of the Company. In such event, the Fair
                  Market Value of such equity security shall be the fair market
                  value per share agreed to by the Board of Directors of the
                  Company AND the Required Holders; PROVIDED, HOWEVER, if no
                  such agreement is

                                     -2-

<PAGE>

                  reached within thirty (30) days of the date on which the
                  event for which the Fair Market Value is required to be
                  determined occurs, then the Fair Market Value shall be
                  determined as follows: the Company and the Required Holders
                  shall each designate promptly in a written notice to the
                  other its determination of the fair market value of such
                  equity security as of the applicable reference date, and
                  the fair market value of such equity security of the as
                  applicable reference date shall then be determined by a
                  nationally recognized independent appraiser (the
                  "Independent Financial Expert") selected by the Required
                  Holders from a group of three appraisers chosen by the
                  Company (with whom the Company does not have an existing
                  business relationship) and the Required Holders assuming an
                  arm's-length private sale between a willing buyer and a
                  willing seller, neither acting under compulsion. The
                  determination by the Independent Financial Expert of the
                  Fair Market Value shall be final and binding on the Company
                  and all Holders. The costs and expenses of any such
                  Independent Financial Expert making such valuation shall be
                  paid by the Company, except that such expenses shall be
                  borne solely by the Holders (on a pro rata basis) to the
                  extent that the Independent Financial Expert concludes that
                  the valuation of such equity security made by the Board of
                  Directors of the Company is within ten percent (10%) of the
                  Fair Market Value.

         For the purposes of the valuations set forth in clauses (i), (ii) or
(iii) above, any equity securities issued by the Company to employees of the
Company pursuant to its employee stock option plan or any other employee benefit
plan shall be deemed to have a Fair Market Value equal to (A) twenty-five
percent (25%) less than the value otherwise determined pursuant to clause (i) or
(ii) above, or (B) twenty-five percent (25%) less than the fair market value
otherwise determined pursuant to clause (iii) above.

         "Independent Financial Expert" shall have the meaning provided in the
definition of "Fair Market Value."

         "Offering Price" shall have the meaning ascribed to such term in
Section 4.1(b) hereof.

         "Qualified Public Market" shall mean with respect to the Common Stock
or other equity securities in the Company, an active trading market on a
national securities exchange or over-the-counter market which consists of such
publicly held Common Stock or other equity securities in the Company, with a
minimum market value of $10,000,000 for such Common Stock or other equity
securities. A "Qualified Public Market" shall be deemed to exist if the
financial parameters set forth in the immediately preceding sentence have bee a
met for the Common Stock or such other equity securities for a period of 21
consecutive days.

         "Warrant Agreement" shall mean the Warrant Agreement, dated as of July
31, 1996, between the Company and the Initial Holders, as supplemented by
Supplement to Warrant Agreement dated as of August 31, 1999, and as such
agreement shall be further modified, amended and supplemented and in effect from
time to time.

                                      -3-

<PAGE>

         Section 2. EXERCISE OF WARRANT: CANCELLATIONS OF WARRANT. This Warrant
may be exercised in whole or in part, at any time or from time to time, during
the Exercise Period, by presentation and surrender hereof to the Company at its
principal office at the address set forth in Section 12 hereof (or at such other
address as the Company may after the date hereof notify the Holder in writing),
with the Purchase Form annexed hereto as Exhibit A duly executed and accompanied
by either (at the option of the Holder) proper payment in cash or check equal to
the Exercise Price for the Warrant Shares for which this Warrant is being
exercised. Notwithstanding the foregoing, if less than all of this Warrant is to
be exercised, the Holder may, at its option, in lieu of delivery of the cash or
check described in the immediately preceding sentence, elect to exercise this
Warrant and to pay the Exercise Price by delivering to the Company a duly
completed and executed Purchase Form providing for the payment of the Exercise
Price by cancellation of a number of Warrant Shares having a Fair Market Value
equal to the Exercise Price of the Warrant Shares issuable upon such exercise.

         Upon receipt by the Company of this Warrant and such Purchase Form,
together with the Exercise Price for the Warrant Shares for which this Warrant
is being exercised, the Holder shall be deemed to be the holder of record of the
number of Warrant Shares specified in such Purchase Form, notwithstanding that
the transfer books of the Company shall then be closed or that certificates (if
any) representing the Warrant Shares shall not then be actually delivered to the
Holder. The Company shall pay any and all documentary stamp or similar issue
taxes payable in respect of the issue of the Warrant Shares. If this Warrant
should be exercised in part only, the Company shall, upon surrender of this
Warrant, execute and deliver a new Warrant evidencing the rights of the Holder
thereof to purchase the balance of the Warrant Shares issuable hereunder.

         Section 3. EXCHANGE, TRANSFER, ASSIGNMENT OR LOSS OF WARRANT. This
Warrant is exchangeable, without expense, at the option of the Holder, upon
presentation and surrender hereof to the Company for other Warrants of different
denominations, entitling the Holder to purchase in the aggregate the same number
of Warrant Shares. The Holder of this Warrant shall be entitled, without
obtaining the consent of the Company, to transfer or assign its interest in (and
rights under) this Warrant in whole or in part to any Person or Persons, subject
to the provisions of Section 6 of the Warrant Agreement. Upon surrender of this
Warrant to the Company, with the Assignment Form annexed hereto as Exhibit B
duly executed and funds sufficient to pay any transfer tax, the Company shall,
without charge, execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees named in such Assignment Form and, if the Holder's entire
interest is not being assigned, in the name of the Holder, and this Warrant
shall promptly be canceled. An assigning Holder shall give prompt written notice
to SunTrust Bank, Atlanta of the consummation of any such assignment (with it
being understood that this sentence shall be of no force and effect if SunTrust
Bank, Atlanta is no longer a Holder or Agent, as defined in the Credit
Agreement). This Warrant may be divided or combined with other Warrants that
carry the same rights upon presentation hereof at the office of the Company,
together with a written notice specifying the names and denominations in which
new Warrants are to be issued and signed by the Holder hereof. Upon receipt by
the Company of evidence satisfactory to it of the loss, theft, destruction or
mutilation of this Warrant, and (in the case of loss, theft or destruction) of
reasonably satisfactory indemnification (including, if required in the
reasonable judgment of the Company, a statement of net worth of such Holder that
is at a level

                                      -4-

<PAGE>

reasonably satisfactory to the Company), and upon surrender and cancellation
of this Warrant, if mutilated, the Company shall execute and deliver a new
Warrant of like tenor and date.

         Section 4.1. ADJUSTMENT OF NUMBER OF WARRANT SHARES AND EXERCISE PRICE.
The number of Warrant Shares purchasable pursuant hereto and the Exercise Price,
each shall be subject to adjustment from time to time on and after the Date of
Issuance as hereinafter provided in this Section 4.1.

         (a) In case the Company shall at any time after the Date of Issuance
(i) declare or pay a dividend in shares of Common Stock or make a distribution
in shares of Common Stock, (ii) subdivide its outstanding shares of Common
Stock, (iii) combine its outstanding shares of Common Stock into a smaller
number of shares of Common Stock or (iv) issue any shares of its capital stock
or other assets in a reclassification or reorganization of the Common Stock
(including any such reclassification in connection with a consolidation or
merger in which the Company is the continuing entity), then (x) the securities
purchasable pursuant hereto shall be adjusted to the number of Warrant Shares
and amount of any other securities, cash or other property of the Company which
the Holder would have owned or have been entitled to receive after the happening
of any of the events described above, had this Warrant been exercised
immediately prior to the happening of such event or any record date with respect
thereto, and (y) the Exercise Price shall be adjusted to equal the Exercise
Price immediately prior to the adjustment multiplied by a fraction, (A) the
numerator of which is the number of Warrant Shares for which this Warrant is
exercisable immediately prior to the adjustment, and (B) the denominator of
which is the number of shares for which this Warrant is exercisable immediately
after such adjustment. The adjustments made pursuant to this Section 4.1(a)
shall become effective immediately after the effective date of the event
creating such right of adjustment, retroactive to the record date, if any, for
such event. Any Warrant Shares purchasable as a result of such adjustment shall
not be issued prior to the effective date of such event.

         (b) In case the Company shall issue shares of its Common Stock or issue
rights, options or warrants to subscribe for or purchase, or other securities
exchangeable for or convertible into, shares of its Common Stock (any such
rights, options, warrants or other securities being herein called "Rights")
(excluding (i) shares issued in a transaction covered by Section 4.1(a) hereof,
(ii) shares issued upon conversion, exercise or exchange of Rights issued after
the date hereof (provided that appropriate adjustments were made hereunder upon
the issuance of such Rights) or (iii) the Warrants and any Warrant Shares issued
on exercise thereof) at an issuance, subscription, offering, exercise or
conversion price (the "Offering Price") per share which is lower than the Fair
Market Value on the date of such issuance or grant, whether or not such Rights
are immediately exercisable or convertible, then (x) the number of Warrant
Shares issuable hereunder after such issuance or, grant shall be determined by
multiplying the number of Warrant Shares immediately prior to any adjustments in
connection with such issuance or grant by a fraction, the numerator of which
shall be the number of shares of Common Stock outstanding (exclusive of any
treasury shares) immediately prior to the date of issuance or grant of such
shares of Common Stock or Rights (assuming that all shares of Common Stock into
which all outstanding rights, options, warrants and convertible securities
excluding the Rights are exercisable or convertible are outstanding) plus the
number of additional shares of Common

                                       -5-

<PAGE>

Stock issued and the number of shares of Common Stock that would be issued
upon exercise of the Rights, and the denominator of which shall be the number
of shares of Common Stock outstanding (exclusive of any treasury shares)
immediately prior to the issuance or grant of such Common Stock or Rights
(assuming that all shares of Common Stock into which all outstanding rights,
options, warrants and convertible securities excluding the Rights are
exercisable or convertible are outstanding) plus the number of shares which
the aggregate Offering Price of the total number of shares of Common Stock
issued or issuable upon exercise of the Rights would purchase at the Fair
Market Value on the date of such issuance or grant, and (y) the Exercise
Price shall be adjusted by multiplying the then existing Exercise Price by
fraction (A) the numerator of which shall be the number of Warrant Shares for
which this Warrant is exercisable immediately prior to such issuance or
grant, and (B) the denominator of which shall be the number of Warrant Shares
for which this Warrant is exercisable immediately after such issuance or
grant; PROVIDED that to the extent any such Rights so issued expire or are
canceled or redeemed without having been exercised or converted, the number
of Warrant Shares issuable hereunder and the Exercise Price shall again be
adjusted to reflect such expiration, cancellation or redemption of such
Rights. Such adjustments shall be made whenever such shares of Common Stock
or Rights are issued or granted. For purposes of this Section 4.1(b), the
Offering Price per share of Common Stock shall in the case of Rights be
determined by dividing (x) the total amount received or receivable by the
Company in consideration of the issuance of such Rights (net of expenses)
plus the total consideration payable to the Company upon exercise thereof by
(y) the total number of shares of Common Stock to be issued pursuant to such
Rights.

         (c) In case the Company shall distribute to all holders of its shares
of Common Stock or rights, options, warrants to subscribe for or purchase, or
other securities exchangeable for or convertible into, shares of Common Stock,
evidences of its Indebtedness or assets (including securities and cash
dividends), but excluding dividends or distributions of the type referred to in
Section 4.1(a) above or rights, options, warrants or other securities referred
to in Section 4.1(b) above (collectively, "Distributions"), then (x) the number
of Warrant Shares issuable hereunder after any such Distribution shall be
determined by multiplying the number of Warrant Shares immediately prior to such
Distribution by a fraction, the numerator of which shall be the Fair Market
Value of the Common Stock on the record date for such Distribution, and the
denominator of which shall be such Fair Market Value of the Common Stock, less
the then fair market value (as determined by the Board of Directors of the
Company, with the Company providing prompt written notice to each Holder of such
determination) of the portion of the assets or evidences of Indebtedness so
distributed applicable to one share of Common Stock, and (y) the Exercise Price
shall be adjusted by multiplying the then existing Exercise Price by a fraction,
(A) the numerator of which shall be the number of Warrant Shares for which this
Warrant is exercisable immediately prior to such Distribution, and (B) the
denominator of which shall be the number of Warrant Shares for which this
Warrant is exercisable immediately after such Distribution. Such adjustments
shall be made successively whenever any such Distribution is made and shall
become effective on the date the Distribution is made retroactive to the record
date for the determination of shareholders entitled to receive such
Distribution. In the event that the Required Holders disagree with the Company's
determination of the fair market value of any assets or evidences of
Indebtedness pursuant to this Section 4.1(c), then such fair market value shall
be determined by an Independent Financial Expert selected by the Required
Holders and the

                                      -6-

<PAGE>

Company in accordance with the procedures set forth in clause (iii) of the
definition of "Fair Market Value."

         (d) For the purpose of this Section 4.1 and Section 4.2 hereof, the
term "'shares of Common Stock" shall mean (i) the classes of stock designated as
the Common Stock of the Company as of the date hereof, (ii) any other class of
stock resulting from successive changes or reclassifications of such shares
consisting solely of changes in par value, or from par value to no par value, or
from no par value to par value, or (iii) any other capital stock of the Company
which is not by its terms restricted in amount or timing to the entitlement to
dividends or in the distribution of assets upon the voluntary or involuntary
liquidation, dissolution or winding up of the Company. In the event that at any
time, as a result of an adjustment made pursuant to this Section 4.1, the Holder
shall become entitled to receive any securities of the Company other than shares
of Common Stock, thereafter the number of such other securities so receivable
upon exercise of this Warrant shall be subject to adjustment from time to time
in a manner and on terms as nearly equivalent as. practicable to the provisions
with respect to the Warrant Shares contained in this Section 4.

         Section 4.2. REORGANIZATION, MERGER, ETC. If any capital
  reorganization, reclassification or similar transaction involving the capital
  stock of the Company (other than as specified in Section 4.l(a) hereof), any
  consolidation, merger or business combination of the Company with another
  corporation or the sale or conveyance of all or any substantial part of its
  assets to another corporation, shall be effected in such a way that holders of
  the shares of Common Stock shall be entitled to receive stock, securities or
  assets (including, without limitation, cash) with respect to or in exchange
  for shares of the Common Stock, then, prior to and as a condition of such
  reorganization, reclassification, similar transaction, consolidation, merger,
  business combination, sale or conveyance, lawful and adequate provision shall
  be made whereby the Holder shall thereafter have the right to purchase and
  receive upon the basis and upon the terms and conditions specified in this
  Warrant and in lieu of the Warrant Shares of the Company immediately
  theretofore purchasable and receivable upon the exercise of this Warrant, such
  shares of stock, securities or assets as may be issued or payable with respect
  to or in exchange for a number of outstanding Warrant Shares equal to the
  number of Warrant Shares immediately theretofore purchasable and receivable
  upon the exercise of this Warrant had such reorganization, reclassification,
  similar transaction, consolidation, merger, business combination, sale or
  conveyance not taken place. The Company shall not effect any such
  consolidation, merger, business combination, sale or conveyance unless prior
  to or simultaneously with the consummation thereof the survivor or successor
  corporation (if other than the Company) resulting from such consolidation or
  merger or the corporation purchasing such assets shall assume by written
  instrument executed and sent to the Holder, the obligation to deliver to the
  Holder such shares of stock, securities or assets as, in accordance with the
  foregoing provisions, the Holder may be entitled to receive.

         4.3. OTHER EVENTS. If any event occurs as to which the foregoing
  provisions of Section 4.1 or 4.2 are not strictly applicable or, if strictly
  applicable, would not, in the good faith judgment of the Board of Directors of
  the Company, fairly and adequately protect the purchase rights represented by
  the Warrants in accordance with the essential intent and principles of such

                                       -7-

<PAGE>

  provisions, then such Board of Directors shall, subject to the provisions of
  Section 4.7 hereof, make such adjustments in the application of such
  provisions, in accordance with such essential intent and principles, as shall
  be reasonably necessary in the good faith opinion of such Board of Directors,
  to protect such purchase rights as aforesaid.

           4.4. STATEMENT ON WARRANT CERTIFICATES. Irrespective of any
  adjustments in the Exercise Price or the number or kind of Warrant Shares,
  this Warrant may continue to express the same price and number and kind of
  shares as are stated on the front page hereof.

           4.5. EXCEPTIONS TO ADJUSTMENT. Anything herein to the contrary
  notwithstanding, the Company shall not be required to make any adjustment of
  the number of Warrant Shares issuable hereunder or to the Exercise Price in
  the case of (i) the issuance of the Warrants or the issuance of shares of the
  Common Stock (or other securities) upon exercise of the Warrants, or (ii) any
  event following the consummation of a Qualified Public Offering.

           4.6. TREASURY SHARES. The number of shares of the Common Stock
  outstanding at any time shall not include treasury shares or shares owned or
  held by or for the account of the Company or any of its subsidiaries, and the
  disposition of any such shares shall be considered an issue or sale of the
  Common Stock for the purposes of this Section 4.

           4.7. COMPANY TO PREVENT DILUTION. In case at any time or from time to
  time conditions arise by reason of action taken by the Company or any of its
  subsidiaries which are not adequately covered by the provisions of this
  Section 4, or which might adversely affect the exercise rights of the Holders,
  the Board of Directors of the Company shall make any adjustments necessary
  with respect to both the number of Warrant Shares into which this Warrant is
  exercisable and the Exercise Price, on a basis consistent with the standards
  established in the other provisions of this Section 4, so as to preserve,
  without dilution, the rights of the Holders. Upon the request of any of the
  Holders, the Company shall retain the services of the Company's independent
  public auditors to review such conditions and provide an agreed upon
  procedures letter as to the calculation of the adjustment under the terms of
  this Agreement, including any comparisons of information to the books and
  records of the Company and any mathematical calculations made.

           4.8. ADJUSTMENT NOTICES TO HOLDER. Upon any increase or decrease in
   the number of Warrant Shares purchasable upon the exercise of this Warrant or
   the Exercise Price the Company shall, within 15 days thereafter, deliver
   written notice thereof to all Holders, which notice shall state the increased
   or decreased number of Warrant Shares purchasable upon the exercise of this
   Warrant, setting forth in reasonable detail the method of calculation and the
   facts upon which such calculations are based. Upon request of the Holder, the
   Company also shall require the Company's independent public auditors to
   provide an agreed upon procedures letter as to the calculation of such
   adjustment under the terms of this Agreement, including any comparisons of
   information to the books and records of the Company and any mathematical
   calculations made. If the Company shall fail to so timely deliver any notice
   required pursuant to this Section 4.8, the Exercise Period shall be extended
   until the Holder shall have received the proper notification under this
   Section 4.8.

                                       -8-

<PAGE>

         5.1. SPECIAL COVENANTS OF THE COMPANY. The Company covenants and agrees
that until this Warrant has been exercised in full:

         (a) The Company shall not, by amendment of its Articles of
Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
directly or indirectly avoid or seek to avoid the observance or performance of
any of the terms of this Warrant or the Warrant Agreement, but shall at all
times in good faith assist in the carrying out of all such terms and in the
taking of all such action as may be necessary or appropriate in order to protect
the rights of the Holder against dilution or other impairment. Without limiting
the generality of the foregoing, the Company (i) shall not increase the par
value of any shares of Common Stock above the Exercise Price payable upon
exercise of this Warrant, and (ii) shall take all such action as may be
necessary or appropriate in order that the Company may validly and legally issue
fully paid and non-assessable Warrant Shares upon the exercise of this Warrant.

         (b) If any Warrant Shares require registration with or approval of any
governmental authority under any federal law (other than the Securities Act) or
under any state law before such Warrant Shares may be issued upon exercise of
this Warrant, the Company shall, at its expense, as expeditiously as possible
use its best efforts to cause such Warrant Shares to be duly registered or
approved, as the case may be.

         (c) If at any time the Common Stock is listed on any national
securities exchange (as defined in the Exchange Act), the Company shall, at its
expense, obtain and maintain the approval for listing on each such exchange upon
official notice of issuance of all Warrant Shares upon the exercise of the
Warrants at the time outstanding and maintain the listing of such Warrant Shares
after their issuance; and the Company shall so list on such national securities
exchange, shall register under the Exchange Act (and any similar state statute
then in effect) and shall maintain such listing of, any other securities that at
any time are issuable upon exercise of the Warrants, if and at the time that any
securities of the same class shall be listed on such national securities
exchange by the Company.

         5.2. PRO RATA PURCHASE. If at any time the Company or any of its
Affiliates shall make an offer to all of its shareholders to purchase any shares
of Common Stock, the Company shall make such offer PRO RATA to all Holders of
outstanding Warrant Shares and Warrants, and any purchase shall be allocated PRO
RATA among the Holders of Warrant Shares and Warrants accepting the offer to
purchase. Further, if at any time the Company or any of its Affiliates shall
make an offer to any of the Holders to purchase any of the Warrants or Warrant
Shares, the Company shall make such offer PRO RATA to all Holders of outstanding
Warrants and Warrant Shares, and any purchase shall be allocated PRO RATA among
the Holders of Warrants and Warrant Shares accepting the offer to purchase. This
Section 5.2 shall not apply to a purchase of Warrants or Warrant Shares by the
Company under Section 6.02 of the Warrant Agreement.

         Section 6. NOTIFICATION BY THE COMPANY. In case at any time while this
Warrant remains outstanding:

                                      -9-
<PAGE>

         (i) the Company shall declare any dividend or make any distribution
upon its Common Stock or any other class of its capital stock; or

         (ii) the Company shall offer for subscription PRO RATA to the holders
of its Common Stock or any other class of its capital stock any additional
shares of stock of any class or any other securities convertible into or
exchangeable for shares of stock or any rights or options to subscribe thereto;
or

         (iii) the Board of Directors of the Company shall authorize any capital
reorganization, reclassification or similar transaction involving the capital
stock of the Company, or a sale or conveyance of all or a substantial part of
the assets of the Company, or a consolidation, merger or business combination of
the Company with another Person; or

         (iv) actions or proceedings shall be authorized or commenced for a
voluntary or involuntary dissolution, liquidation or winding-up of the Company;

then, in any one or more of such cases, the Company shall give written notice to
the Holder, at the earliest time legally practicable (and not less than 30 days
before any record date or other date set for definitive action) of the date on
which (A) the books of the Company shall close or a record shall be taken for
such dividend, distribution or subscription rights or options or (B) such
reorganization, reclassification, sale, conveyance, consolidation, merger,
dissolution, liquidation or winding-up shall take place or be voted on by
shareholders of the Company, as the case may be. Such notice shall also specify
the date as of which the holders of the Common Stock of record shall participate
in said dividend, distribution, subscription rights or options or shall be
entitled to exchange their Common Stock for securities or other property
deliverable upon such reorganization, reclassification, sale, conveyance,
consolidation, merger, dissolution, liquidation or winding-up, as the case may,
be. If the action in question or the record date is subject to the effectiveness
of a registration statement under the Securities Act or to a favorable vote of
shareholders, the notice required by this Section 6 shall so state.

         Section 7. NO VOTING RIGHTS: LIMITATIONS OF LIABILITY. Prior to
exercise, this Warrant will not entitle the Holder to any voting rights or other
rights as a shareholder of the Company. No provision hereof, in the absence of
affirmative action by the Holder to exercise this Warrant, and no enumeration
herein of the rights or privileges of the Holder, shall give rise to any
liability of the Holder for the purchase price of the Warrant Shares pursuant to
the exercise hereof.

         Section 8. DATE OF ISSUANCE. The date the Company initially issues this
Warrant will be deemed to be the 'Date of Issuance" hereof and of each new
Warrant issued in exchange, transfer or replacement hereof, regardless of the
number of times new certificates representing the unexpired and unexercised
rights formerly represented by this Warrant shall be issued.

                                      -10-

<PAGE>

         Section 9. AMENDMENT AND WAIVER. (a) No failure or delay of the Holder
in exercising any power or right hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of such right or power, or any
abandonment or discontinuance of steps to enforce such a right or power,
preclude any other or further exercise thereof or the exercise of any other
right or power. The rights and remedies of the Holder are cumulative and not
exclusive of any rights or remedies which it would otherwise have. The
provisions of this Warrant may be amended, modified or waived with (and only
with) the written consent of the Company and the Required Holders.

         (b) No notice or demand on the Company in any case shall entitle the
Company to any other or further notice or demand in similar or other
circumstances.

         Section 10. NO FRACTIONAL WARRANT SHARES. The Company shall not be
required to issue stock certificates representing fractions of Warrant Shares,
but shall in respect of any fraction of a Warrant Share make a payment in cash
based on the then Fair Market Value of the Common Stock after giving effect to
the full exercise or conversion of the Warrants.

         Section 11. RESERVATION OF WARRANT SHARES. The Company shall authorize,
reserve and keep available at all times, free from preemptive rights, a
sufficient number of Warrant Shares to satisfy the requirements of this Warrant.

         Section 12. NOTICES. All notices, requests, consents and other
communication., hereunder shall be in writing (including, telegraphic, telex,
facsimile or cable communication) and delivered, mailed telegraphed, telexed,
telecopied or cabled:

         (i) if to the Holder, to its address as set forth in records of the
Company; and

         (ii) if to the Company, to Vari-Lite International, Inc., at 201 Regal
Row, Dallas Texas 75247, Telecopier No.: (214) 819-3247, Attention: H.R.
Brutsche III or at such other address as may have been furnished to the Holder
in writing by the Company.

         All such communications shall be deemed to have been duly given when
transmitted by telex or telecopier, delivered to the telegraph or cable office
or personally delivered or, iii the case of a mailed notice, upon receipt, in
each case given or addressed as aforesaid.

         Section 13. HEADINGS. The headings of the Sections and subsections of
this Warrant are inserted for convenience only and shall not be deemed to
constitute a part of this Warrant.

         Section 14. GOVERNING LAW; CONSENT TO JURISDICTION. THIS WARRANT SHALL
BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW
YORK. If any action or proceeding shall be brought by the Holder in order to
enforce any right of obligation in respect of this Warrant, the Company hereby
consents and will submit to the jurisdiction of any state or federal court of
competent jurisdiction sitting within the area comprising the Southern District
of New York on the date of this Warrant, and agrees that venue will be proper in
any such court.

                                      -11-

<PAGE>

         Section 15. BINDING EFFECT. The terms and provisions of this Warrant
shall inure to the benefit of the Holder and its successors and assigns and
shall be binding upon the Company and its successors and assigns, including,
without limitations any Person succeeding to the Company by merger,
consolidation or acquisition of all or substantially all of the Company's
assets.

                                     -12-

<PAGE>

         IN WITNESS WHEREOF, the seal of the Company and the signature of its
duly authorized officer have been affixed hereto as of August 31, 1999.

                                                 VARI-LITE INTERNATIONAL, INC.

                                                 By:
                                                     -----------------------
                                                      H.R. Brutsche III
                                                      President

[CORPORATE SEAL]

Attest:
       ------------------------------
       Name:
       Title:

                             Warrant Signature Page

                                      -13-

<PAGE>

                                    EXHIBIT A
                                       TO
                                     WARRANT

                                  PURCHASE FORM

                          To Be Executed by the Holder
                        Desiring to Exercise a Warrant of
                          Vari-Lite International, Inc.

        The undersigned holder hereby exercises the right to purchase _______
shares of Common Stock covered by the within Warrant, according to the
conditions thereof, and herewith makes payment in full of the Exercise Price of
such shares, in the amount of $______________.

                                 Name of Holder:

                                 -------------------------------------------

                                 Signature:
                                           ---------------------------------
                                 Title:
                                       -------------------------------------

                                 Address:
                                         -----------------------------------

                                 -------------------------------------------

Dated:
      -----------------------

<PAGE>

                                    EXHIBIT B
                                       TO
                                     WARRANT

                                 ASSIGNMENT FORM

                          To Be Executed by the Holder
                        Desiring to Transfer a Warrant of
                          Vari-Lite International, Inc.

         FOR VALUE RECEIVED, the undersigned holder hereby sells, assigns and
transfers unto _____________ the right to purchase _______________ shares of
Common Stock covered by the within Warrant, and does hereby irrevocably
constitute and appoint Attorney to transfer the said Warrant on the books of
the Company (as defined in such Warrant), with full power of substitution.

                                 Name of Holder:

                                 -------------------------------------------

                                 Signature:
                                           ---------------------------------
                                 Title:
                                       -------------------------------------

                                 Address:
                                         -----------------------------------

                                 -------------------------------------------

Dated:
      ------------------------

In the presence of

------------------------------

                                     NOTICE:

The signature to the foregoing Assignment Form must correspond to the name as
written upon the face of the within Warrant in every detail, without alteration
or enlargement or any change whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]